RCS - Releaf Dispensary Ld - Releaf Achieves Industry-First B Corp Status
Releaf Achieves Cannabis Industry-First B Corp Status
Releaf, the UK's leading medical cannabis clinic, has today announced it has become the first medical cannabis clinic to achieve B Corp certification.
Verified by the non-profit B Lab, the certification follows a rigorous process over months of assessment, demonstrating that Releaf meets high standards of social and environmental performance, transparency and accountability.
For a sector that has spent years defending its clinical credibility, this achievement is a significant marker of legitimacy built on independent verified proof of business operations for patients, team and the wider community
Mason Soiza, Founder of Releaf, said, "Achieving B Corp certification means an independent body has reviewed everything from our care model to governance, impact on patients, people and the wider community, and confirmed it meets a high standard."
"We're the first medical cannabis clinic to achieve this, which matters because our industry is still proving its legitimacy, so independent verification carries more weight than anything we could say about ourselves."
Medical cannabis, although legal in the UK since 2018, remains a young category of healthcare still facing stigma. Patients considering treatment have to weigh up clinical need against uncertainty of a provider they can trust. This certification gives patients an additional layer of reassurance when looking at medical cannabis treatment.
Amy Jones, HR Manager at Releaf, said, "Being part of B Corp means holding ourselves to the same standard we set for patient care, doing right by our people, our patients and the communities we work in. We're proud to part of a community of organisations who share our values."
Alongside a commitment to goals beyond shareholder value, the certification also means joining a global community of over 10,700 businesses acting as a force for good.
Releaf will publish its first B Corp Impact report later this month, illustrating its progress across people, environment, community and governance, and the targets it has committed to for the year ahead.
[END]
About Releaf
Launched in 2024, Releaf is the UK's fastest-growing and most-trusted* medical cannabis clinic, serving patients through its advanced healthtech platform. With a prescriber base of over 60 specialists, we deliver evidence-based cannabinoid care directly to patients' homes through tailored treatment plans. Integrated with NHS systems, Releaf has transformed access to medicinal cannabis treatment in the UK and is now expanding internationally. According to Trustpilot (8,800 reviews) and Medical Cannabis independent industry site.
Releaf Dispensary Ltd.
For more information contact press@releaf.co.uk or visit www.releaf.co.uk
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNRAFIFLTDVIAIIR
